InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Burris Jeffrey W. Director active across 1 company, notably Indivior Pharmaceuticals, Inc.. In total, 2 disclosures have been published. History available since 10 February 2026. The latest transaction was filed on 10 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations